Literature DB >> 27618738

Changing Provider Behavior in the Context of Chronic Disease Management: Focus on Clinical Inertia.

Kim L Lavoie1,2, Joshua A Rash3, Tavis S Campbell3.   

Abstract

Widespread acceptance of evidence-based medicine has led to the proliferation of clinical practice guidelines as the primary mode of communicating current best practices across a range of chronic diseases. Despite overwhelming evidence supporting the benefits of their use, there is a long history of poor uptake by providers. Nonadherence to clinical practice guidelines is referred to as clinical inertia and represents provider failure to initiate or intensify treatment despite a clear indication to do so. Here we review evidence for the ubiquity of clinical inertia across a variety of chronic health conditions, as well as the organizational and system, patient, and provider factors that serve to maintain it. Limitations are highlighted in the emerging literature examining interventions to reduce clinical inertia. An evidence-based framework to address these limitations is proposed that uses behavior change theory and advocates for shared decision making and enhanced guideline development and dissemination.

Entities:  

Keywords:  clinical inertia; clinical practice guidelines; diagnostic inertia; evidence-based medicine; therapeutic inertia

Mesh:

Year:  2016        PMID: 27618738     DOI: 10.1146/annurev-pharmtox-010716-104952

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  13 in total

1.  Linking Reminders and Physician Breast Cancer Screening Recommendations: Results From a National Survey.

Authors:  Elizabeth J Siembida; Archana Radhakrishnan; Sarah A Nowak; Andrew M Parker; Craig Evan Pollack
Journal:  JCO Clin Cancer Inform       Date:  2017-11

2.  Replicating dissemination and identifying mechanisms of implementation of an empirically supported treatment.

Authors:  Stephen B Lo; Claire C Conley; Brittany M Brothers; Marlena M Ryba; Georita F Frierson; Rebecca A Shelby; Lisa M Thornton; Kristen M Carpenter; Barbara L Andersen
Journal:  Health Psychol       Date:  2021-07       Impact factor: 5.556

3.  Eligibility and Usage of Sacubitril/Valsartan in Korea.

Authors:  Jin-Jin Kim; Jong-Chan Youn
Journal:  Int J Heart Fail       Date:  2019-10-29

4.  The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results.

Authors:  Steven Shea; John L P Thompson; Joseph E Schwartz; Yineng Chen; Morgan de Ferrante; Alyssa M Vanderbeek; Richard Buchsbaum; Celibell Vargas; Khan M Siddiqui; Andrew E Moran; Melissa Stockwell
Journal:  Am J Hypertens       Date:  2022-01-05       Impact factor: 3.080

5.  Enablers and determinants of the provision of written action plans to patients with asthma: a stratified survey of Canadian physicians.

Authors:  Fabienne Djandji; Alexandrine J Lamontagne; Lucie Blais; Simon L Bacon; Pierre Ernst; Roland Grad; Kim L Lavoie; Martha L McKinney; Eve Desplats; Francine M Ducharme
Journal:  NPJ Prim Care Respir Med       Date:  2017-03-31       Impact factor: 2.871

6.  Factors associated with initiation and persistence of urate-lowering therapy.

Authors:  Mats Dehlin; Emin Hoxha Ekström; Max Petzold; Ulf Strömberg; Gunilla Telg; Lennart T H Jacobsson
Journal:  Arthritis Res Ther       Date:  2017-01-17       Impact factor: 5.156

7.  Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review.

Authors:  Joshua A Rash; Norman Buckley; Jason W Busse; Tavis S Campbell; Kim Corace; Lynn Cooper; David Flusk; Alfonso Iorio; Kim L Lavoie; Patricia A Poulin; B Skidmore
Journal:  Syst Rev       Date:  2018-11-13

8.  Alerting Doctors About Patient Life Challenges: A Randomized Control Trial of a Previsit Inventory of Contextual Factors.

Authors:  Frances M Weaver; Amy Binns-Calvey; Beverly Gonzalez; Carol Kostovich; Sherri LaVela; Kevin T Stroupe; Brendan Kelly; Naomi Ashley; Scott Miskevics; Ben Gerber; Lisa Burkhart; Alan Schwartz; Saul J Weiner
Journal:  MDM Policy Pract       Date:  2019-05-27

9.  What factors could influence physicians' management of women of childbearing age with chronic inflammatory disease? A systematic review of behavioural determinants of clinical inertia.

Authors:  Catherine Nelson-Piercy; Ivo Vlaev; Katie Harris; Rebecca Fischer-Betz
Journal:  BMC Health Serv Res       Date:  2019-11-21       Impact factor: 2.655

Review 10.  Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.

Authors:  Guntram Schernthaner; Naim Shehadeh; Alexander S Ametov; Anna V Bazarova; Fahim Ebrahimi; Peter Fasching; Andrej Janež; Péter Kempler; Ilze Konrāde; Nebojša M Lalić; Boris Mankovsky; Emil Martinka; Dario Rahelić; Cristian Serafinceanu; Jan Škrha; Tsvetalina Tankova; Žydrūnė Visockienė
Journal:  Cardiovasc Diabetol       Date:  2020-10-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.